SKA3 and cholangiocarcinoma: The subcutaneous tumour formation experiment in mice showed that gemcitabine obviously decreased the volume and weight of the subcutaneous tumour, while SKA3 overexpression decreased the sensitivity of CCA cells to gemcitabine (Fig. 8D-F).